TickerFacts.

Fractyl Health, Inc. (GUTS): Capital Expenditures

Annual figures by period end, from SEC filings.

$557.0K
Year ended 2025-12-31
$1.76M2023-12-31: $359.0K2024-12-31: $1.76M2025-12-31: $557.0K$557.0K
2023-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$557.0K-68.4%2026-03-24, From 2025-01-01
2024-12-31$1.76M+391.6%2026-03-24, From 2024-01-01
2023-12-31$359.0Kn/a2025-03-03, From 2023-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Fractyl Health, Inc. (GUTS)2025-12-31$557.0K-68.4%
Baxter International Inc (BAX)2025-12-31$513.00M+15.0%
Becton Dickinson & Co (BDX)2025-09-30$760.00M+4.8%
3M Co (MMM)2025-12-31$910.00M-22.9%
Teleflex Inc (TFX)2025-12-31$95.24M+5.3%
West Pharmaceutical Services Inc (WST)2025-12-31$285.90M-24.2%
Stryker Corp (SYK)2025-12-31$761.00M+0.8%
Haemonetics Corp (HAE)2026-03-28$32.78M-16.5%
KORU Medical Systems, Inc. (KRMD)2025-12-31$932.5K-28.1%

Compare GUTS, BAX, BDX, MMM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗